1. Anti‐inflammatory therapy with tumour necrosis factor inhibitors is associated with reduced risk of major adverse cardiovascular events in psoriasis. (1st May 2018) Authors: Wu, J.J.; Joshi, A.A.; Reddy, S.P.; Batech, M.; Egeberg, A.; Ahlehoff, O.; Mehta, N.N. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 8(2018) Page Start: 1320 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti‐inflammatory drugs: a Danish real‐world cohort study. (11th October 2012) Authors: Ahlehoff, O.; Skov, L.; Gislason, G.; Lindhardsen, J.; Kristensen, S. L.; Iversen, L.; Lasthein, S.; Gniadecki, R.; Dam, T. N.; Torp‐Pedersen, C.; Hansen, P. R. Journal: Journal of internal medicine Issue: Volume 273:Number 2(2013:Feb.) Page Start: 197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cardiovascular outcomes and systemic anti‐inflammatory drugs in patients with severe psoriasis: 5‐year follow‐up of a Danish nationwide cohort. (10th October 2014) Authors: Ahlehoff, O.; Skov, L.; Gislason, G.; Gniadecki, R.; Iversen, L.; Bryld, L.E.; Lasthein, S.; Lindhardsen, J.; Kristensen, S.L.; Torp‐Pedersen, C.; Hansen, P.R. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29:Number 6(2015:Jun.) Page Start: 1128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0115 Non-steroidal anti-inflammatory drug use and the risk of cardiovascular disease in patients with rheumatoid arthritis – is there a risk?. (23rd January 2014) Authors: Lindhardsen, J.; Ahlehoff, O.; Gislason, G.H.; Madsen, O.R.; Jacobsen, S.; Torp-Pedersen, C.; Hansen, P.R. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Hidradenitis suppurativa is associated with myocardial infarction, but not stroke or peripheral arterial disease of the lower extremities. (1st March 2018) Authors: Miller, I.M.; Ahlehoff, O.; Zarchi, K.; Rytgaard, H.; Mogensen, U.B.; Ellervik, C.; Jemec, G.B. Journal: British journal of dermatology Issue: Volume 178:Number 3(2018) Page Start: 790 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Hidradenitis suppurativa is associated with myocardial infarction, but not stroke or peripheral arterial disease of the lower extremities. (8th January 2018) Authors: Miller, I.M.; Ahlehoff, O.; Zarchi, K.; Rytgaard, H.; Mogensen, U.B.; Ellervik, C.; Jemec, G.B. Journal: British journal of dermatology Issue: Volume 178:Number 3(2018) Page Start: 790 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Hidradenitis suppurativa may not be associated with venous thromboembolia: Results from a large Danish cross-sectional study. Issue 1 (January 2016) Authors: Miller, I.M.; Ahlehoff, O.; Ibler, K.; Rytgaard, H.; Mogensen, U.B.; Ellervik, C.; Jemec, G.B. Journal: Journal of dermatological science Issue: Volume 81:Issue 1(2016:Jan.) Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Myocardial function and effects of biologic therapy in patients with severe psoriasis: a prospective echocardiographic study. (6th April 2015) Authors: Ahlehoff, O.; Hansen, P.R.; Gislason, G.H.; Frydland, M.; Bryld, L.E.; Elming, H.; Jemec, G.B.E. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 30:Number 5(2016:May) Page Start: 819 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Nationwide population‐based study of cause‐specific death rates in patients with psoriasis. (9th June 2014) Authors: Salahadeen, E.; Torp‐Pedersen, C.; Gislason, G.; Hansen, P.R.; Ahlehoff, O. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29:Number 5(2015:May) Page Start: 1002 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Response: psoriasis treatment should be stratified in order to better assess the cardiovascular event rates. (7th May 2013) Authors: Ahlehoff, O.; Hansen, P. R. Journal: Journal of internal medicine Issue: Volume 274:Number 3(2013:Sep.) Page Start: 290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗